Call for a Translational Orthobiologics Fellowship in the Era of Regenerative Medicine
- PMID: 40434440
- DOI: 10.1097/PHM.0000000000002782
Call for a Translational Orthobiologics Fellowship in the Era of Regenerative Medicine
Abstract
Regenerative medicine is a rapidly advancing field, particularly within the field of physical medicine and rehabilitation. While orthobiologics are currently being used in clinical practice, there remains a need for high-quality clinical trials and translational research to standardize treatments and improve patient outcomes. Education is vital for streamlining development of evidence-based, practical, and effective treatments. In this article, we highlight the need for a 1-yr advanced fellowship in translational orthobiologics aiming to create a standardized core curriculum targeting physicians involved in treating musculoskeletal diseases. The fellowship's objectives include advancing translational orthobiologics research, ethical considerations, and promoting effective communication regarding orthobiologic therapies. Such a program would serve as a foundation for physicians interested in conducting clinically oriented orthobiologics research for musculoskeletal disorders while improving the development of safe and effective therapeutics related to musculoskeletal disorders.
Keywords: Clinical Trials; Orthobiologics; Regenerative Rehabilitation; Research.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article.
References
-
- Mason C, Dunnill P: A brief definition of regenerative medicine. Regenerative Med . 2008;3:1–5
-
- Li T, Luo C, Zhang J, et al.: Efficacy and safety of mesenchymal stem cells co-infusion in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis. Stem Cell Res Ther 2021;12:246
-
- West TA, Williams ML: Orthobiologics. Clin Podiatr Med Surg 2019;36:609–26
-
- Everts P, Onishi K, Jayaram P, et al.: Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. Int J Mol Sci 2020;21:7794
-
- Finnoff JT, Awan TM, Borg-Stein J, et al.: American Medical Society for Sports Medicine position statement: principles for the responsible use of regenerative medicine in sports medicine. Clin J Sport Med 2021;31:530–41
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
